Terran Cooper, the regulatory consultant at Falcon Rappaport & Berkman LLP, a key cannabis law firm shared “It seems that many people are alarmed upon the realization that the very agency tasked with enforcing the Controlled Substances Act, is also the one tasked with potentially rescheduling cannabis.”
“The only confidence that DEA will choose to reschedule cannabis comes from precedent. The Congressional Research Service reported that they were unaware of any instances where the DEA rejected a rescheduling recommendation by the FDA & HHS. While the DEA can, and ultimately may, decide not to reschedule cannabis – it would be an unprecedented move.” shared Cooper.
Source link
